TimothyPCripeMDPhD
Pediatric Hematology & Oncology • Columbus, OHProfessor, Pediatrics, Ohio State University College of Medicine
Dr. Cripe is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
700 Childrens Dr
Columbus, OH 43205Phone+1 614-722-3552Fax+1 614-722-3699
Education & Training
University of ColoradoFellowship, Pediatric Hematology/Oncology, 1993 - 1995
University of Iowa Hospitals and ClinicsResidency, Pediatrics, 1989 - 1992
University of Iowa Roy J. and Lucille A. Carver College of MedicineClass of 1989
Certifications & Licensure
OH State Medical License 1999 - 2025
CO State Medical License 1993 - 2009
WI State Medical License 1995 - 2001
IL State Medical License 1995 - 1999
IA State Medical License 1989 - 1994- American Board of Pediatrics Pediatric Hematology-Oncology
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014-2020
Clinical Trials
- HSV1716 in Patients With Non-Central Nervous System (Non-CNS) Solid Tumors Start of enrollment: 2010 Mar 01
- Safety Study of Recombinant Vaccinia Virus to Treat Refractory Solid Tumors in Pediatric Patients Start of enrollment: 2010 Aug 01
- Ph1 Administration of VSV-IFNβ-NIS Monotherapy and in Combination With Avelumab in Pts With Refractory Solid Tumors Start of enrollment: 2017 Apr 17
Publications & Presentations
PubMed
- 35 citationsOncolytic virotherapy reaches adolescence.Adrienne M. Hammill, Joseph Conner, Timothy P. Cripe
Pediatric Blood & Cancer. 2010-12-15 - 36 citationsTumor-Associated Macrophages in Oncolytic Virotherapy: Friend or Foe?Nicholas L Denton, Chun-Yu Chen, Thomas Scott, Timothy P. Cripe
Biomedicines. 2016-07-07 - 121 citationsA Novel Class of Anticancer Compounds Targets the Actin Cytoskeleton in Tumor CellsJustine R. Stehn, Nikolas K. Haass, Theresa Bonello, Melissa Desouza, Gregg Kottyan
Cancer Research. 2013-08-15
Press Mentions
- TWiPO #93: CureWorks & Caring Cross: Pathways to Advance Cell & Gene Therapy with Dr. Rimas OrentasJanuary 20th, 2022
- Collaboration Between Rheumatologists, Primary Care Reduces Delay in Axial SpA DiagnosisAugust 4th, 2021
Shop TalkNovember 5th, 2019- Join now to see all
Grant Support
- Xenograft Core For NF1 Experimental TherapeuticsNational Institute Of Neurological Disorders And Stroke2010–2011
- Phase I Study Of Hsv1716 In Pediatric Non-Cns Solid Tumors,Ind 13196 12/04/2006Food And Drug Administration2010–2011
- Oncolytic HSV Therapy In Immunocompetent Sarcoma ModelsNational Cancer Institute2010
- Xenograft Core For NF1 Experimental TherapeuticsNational Institute Of Neurological Disorders And Stroke2008–2009
- Virotherapy For Neuroblastoma Stem CellsNational Cancer Institute2008–2009
- Oncolytic HSV Therapy In Immunocompetent Sarcoma ModelsNational Cancer Institute2006–2009
- Regulated Toxin Gene Therapy For RhabdomyosarcomaNational Cancer Institute1999–2001
- Regulated Toxin Gene Therapy For RhabdomyosarcomaNational Cancer Institute1997–1999
- HSC 70 And Agnoprotein In Papovavirus AssemblyNational Institute Of Allergy And Infectious Diseases1995–1997
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
